Objectives: Neurocutaneous melanosis (NCM) in adult patients was rare, and few cases had been reported. In this report, we summarized the features of NCM in adult patients for providing useful information about this rare clinical entity. Methods: In this report, we present a case of a 41-year-old woman, who was eventually diagnosed with NCM with intraspinal malignant melanoma. The clinical features, treatments, and prognosis of cases of NCM in adults were thoroughly reviewed and discussed. Results: A 41-year-old woman was eventually diagnosed with NCM with intraspinal malignant melanoma. The post-operative course was uneventful and her symptoms significantly improved (VAS: 3 points). However, she developed symptoms of intracranial hypertension and deteriorated rapidly after 11 months of operation, and died 1 month later. To date, only 15 cases of NCM in adults have been reported in the English literature. Analyses showed that the average age was 33.8 years (range 19-65 years), and 11 patients (68.8%) were between 20 and 40 years. A slight male predominance (M:F/11:5) was found. For the 12 cases which detailed follow-up information was available, 9 patients (75%) died, with a survival time ranging from 1 day to 29 months post-operation. Death occurred within the first month of operation in 6 cases (46. 2%). The median survival time was 3 months. Conclusions: We presented a rare case of NCM with intraspinal malignant melanoma in an adult patient. Although rare, this clinical entity causes significant mortality and has poor prognosis.
Introduction
Neurocutaneous melanosis (NCM), first described by Rokitansky in 1861, is a congenital, nonheritable phakomatosis, which was generally thought to result from neuroectodermal dysplasia in which the neural crest cells erroneously migrate to the skin and pia mater [1] [2] [3] . In 1991, Kadonaga and Frieden reviewed the features of NCM and proposed the currently accepted modified criteria [4] (Table 1) . When neurological signs are present in children, death occurs within 3 years after a rapid deteriorating course [5] . To date, there are only 15 reported cases of NCM confirmed by histopathology in adult patients [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . In this report, we present a case of a woman diagnosed with NCM with intraspinal malignant melanoma. The detailed clinical description and systematic analyses in conjunction with the related literature review are provided as well.
Case report
A 41-year-old woman presented in our hospital with a 5-month history of progressive low back and left lower extremity pain. On presentation, her visual analog scale (VAS) score was 8 points. The patient's physical and neurological examination results were normal. Laboratory findings were within normal levels. Her medical history consisted of a giant congenital blue nevus occupying the back at birth (Figure 1a) .
Magnetic resonance imaging (MRI) revealed compression and distortion of the spinal cord caused by intraspinal multi-nodules at the level of T6 through L1, which were hyperintense on the T1-weighted MR image (T1WI) and hypointense on the T2-weighted image (T2WI). The MR images obtained after gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) injection clearly showed homogenous enhancement of the lesions on T1-weighted images (Figure 2) . The cervical spine and intracranial lesions were not observed on the series of MR images. Based on the neuroimaging results, intraspinal neurofibroma was suspected. Skin biopsy on the back revealed congenital nevi of the common melanocytic type.
A T11-L1 laminectomy with neurophysiological monitoring was performed via a posterior approach. The spinal cord and cauda equina were surrounded by dark black soft tissues with irregular and indistinct margins that could be sucked in (Figure 1b) . Two dark black nodules were solid and tightly adherent to the dorsal surface of the spinal cord, and were almost totally resected.
In the histopathological examination, there were malignant tumors containing variable amount of melanin with areas of necrosis and foci of parenchymal infiltration. Nuclear pleomorphism with occasional mitotic figures was observed (Figure 3) . Immunohistochemical determination showed that the nodules were positive for HMB-45, S-100, and Melan A, while negative for epithelial membrane antigen Table 1 Neurocutaneous melanosis (NCM) criteria as proposed by Kadonaga and Frieden [4] 1. Large or multiple congenital melanocytic nevi associated with meningeal melanosis or melanoma. ("Large" >20 cm in adults, >9 cm on the head, or 6 cm on the body in infants; "multiple" >2)
2. No evidence of cutaneous melanoma except in patients for whom the examined areas of meningeal lesions are histologically benign.
3. No evidence of meningeal melanoma, except in patients for whom the examined areas of cutaneous lesions are histologically benign. (EMA). Final diagnosis was confirmed as NCM with intraspinal malignant melanoma. Adjuvant chemotherapy was followed. The postoperative course was uneventful and her symptoms significantly improved (VAS: 3 points). However, she developed symptoms of intracranial hypertension and deteriorated rapidly after 11 months of operation, and died 1 month later. An autopsy was not permitted.
Discussion
NCM is a rare disorder characterized by lesions with poor prognosis. Neurologic manifestations of NCM appear generally in the first 2 years after birth, or later in the second decade of life. Within 3 years of the initial symptoms, death occurs in more than 50% of patients [1] . Fifteen reported cases of NCM confirmed by histopathology in adult patients plus the present case in our experience have been summarized to characterize this clinical entity [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Analyses showed that the average age was 33.8 years (range 19-65 years), and 11 patients (68.8%) were between 20 and 40 years. A slight male predominance (M:F/11:5) was found. However, there was no gender preference in children [2] .
The major clinical manifestations were symptoms related to increased intracranial pressure or hydrocephalus, such as headache, vomiting, and diplopia (56.2%), epilepsy (25%) and weakness (18.8%). In one case, the initial presentation was with excessive sweating of the palms and soles, followed by numbness of the extremities [7] . Patients with bladder or bowel dysfunction, or developmental delay have not been previously reported. Our case presented progressive low back and left lower extremity pain without increased intracranial pressure or epilepsy as the symptom. We thought that the symptom was caused by spinal cord compression and infiltration of malignant melanocytes. The onset of symptoms varied widely. The incubation period ranged from 1 week to 10 years, while the average period was 25 months, which was shorter than in patients with the symptom of seizures (average period: 61 months).
Once NCM is clinically suspected, MRI with gadolinium contrast is the best diagnostic choice. Generally, the most frequent MRI finding is linear or mass hyperintense signals on T1WI or hypointense signal on T2WI with homogenous enhancement. Six patients (37.5%) had hydrocephalus. In children, approximately two thirds developed hydrocephalus [21, 22] . Three cases (18.8%) showed Dandy-Walker malformation, and 2 cases (12.5%) showed intracranial dermoid tumor. Locations of linear or mass lesions varied from the cerebral fissures and sulci to the cisterns. Our case is the only reported presentation of NCM with malignant melanomas located in the spinal cord in adults.
Unfortunately, although surgery was principally performed, radical removal was largely impossible due to massive infiltration and rapid relapses of masses. The main purpose of the operation was to relieve the neurological symptoms and ensure histological diagnosis. Neither chemotherapy nor radiation therapy has been shown to improve the outcome. Although this disease is rare in adults, the prognosis is considerably worse in adult patients. For the 12 cases for which detailed follow-up information was available, 9 patients (75%) died, with a survival time ranging from 1 day to 29 months post-operation. Death occurred within the first month of operation in 6 cases (46.2%). The median survival time was 3 months (statistical analyses conducted using SPSS 18.0 for Windows).
Conclusions
We presented a case of a rare reported presentation of NCM with intraspinal malignant melanoma in an adult patient. Although rare, this clinical entity causes significant mortality and has poor prognosis.
